COVID-19 Impact on ß-blockers Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on ß-blockers Industry
1.7 COVID-19 Impact: ß-blockers Market Trends
2 Global ß-blockers Quarterly Market Size Analysis
2.1 ß-blockers Business Impact Assessment - COVID-19
2.1.1 Global ß-blockers Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global ß-blockers Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global ß-blockers Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global ß-blockers Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global ß-blockers Factory Price by Manufacturers
3.3 Location of Key Manufacturers ß-blockers Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into ß-blockers Market
3.5 Key Manufacturers ß-blockers Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on ß-blockers Segments, By Type
4.1 Introduction
1.4.1 Nonselective Agents
1.4.2 Selective Agents
4.2 By Type, Global ß-blockers Market Size, 2019-2021
4.2.1 By Type, Global ß-blockers Market Size by Type, 2020-2021
4.2.2 By Type, Global ß-blockers Price, 2020-2021
5 Impact of Covid-19 on ß-blockers Segments, By Application
5.1 Overview
5.5.1 Abnormal Heart Rhythms
5.5.2 Hypertension
5.2 By Application, Global ß-blockers Market Size, 2019-2021
5.2.1 By Application, Global ß-blockers Market Size by Application, 2019-2021
5.2.2 By Application, Global ß-blockers Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Business Overview
7.1.2 Pfizer ß-blockers Quarterly Production and Revenue, 2020
7.1.3 Pfizer ß-blockers Product Introduction
7.1.4 Pfizer Response to COVID-19 and Related Developments
7.2 Novartis
7.2.1 Novartis Business Overview
7.2.2 Novartis ß-blockers Quarterly Production and Revenue, 2020
7.2.3 Novartis ß-blockers Product Introduction
7.2.4 Novartis Response to COVID-19 and Related Developments
7.3 Merck
7.3.1 Merck Business Overview
7.3.2 Merck ß-blockers Quarterly Production and Revenue, 2020
7.3.3 Merck ß-blockers Product Introduction
7.3.4 Merck Response to COVID-19 and Related Developments
7.4 Astra Zeneca
7.4.1 Astra Zeneca Business Overview
7.4.2 Astra Zeneca ß-blockers Quarterly Production and Revenue, 2020
7.4.3 Astra Zeneca ß-blockers Product Introduction
7.4.4 Astra Zeneca Response to COVID-19 and Related Developments
7.5 Jhonson and Johnson
7.5.1 Jhonson and Johnson Business Overview
7.5.2 Jhonson and Johnson ß-blockers Quarterly Production and Revenue, 2020
7.5.3 Jhonson and Johnson ß-blockers Product Introduction
7.5.4 Jhonson and Johnson Response to COVID-19 and Related Developments
7.6 Eli Lilly
7.6.1 Eli Lilly Business Overview
7.6.2 Eli Lilly ß-blockers Quarterly Production and Revenue, 2020
7.6.3 Eli Lilly ß-blockers Product Introduction
7.6.4 Eli Lilly Response to COVID-19 and Related Developments
7.7 Sanofi
7.7.1 Sanofi Business Overview
7.7.2 Sanofi ß-blockers Quarterly Production and Revenue, 2020
7.7.3 Sanofi ß-blockers Product Introduction
7.7.4 Sanofi Response to COVID-19 and Related Developments
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Business Overview
7.8.2 Bristol-Myers Squibb ß-blockers Quarterly Production and Revenue, 2020
7.8.3 Bristol-Myers Squibb ß-blockers Product Introduction
7.8.4 Bristol-Myers Squibb Response to COVID-19 and Related Developments
7.9 Bayer
7.9.1 Bayer Business Overview
7.9.2 Bayer ß-blockers Quarterly Production and Revenue, 2020
7.9.3 Bayer ß-blockers Product Introduction
7.9.4 Bayer Response to COVID-19 and Related Developments
7.10 GSK
7.10.1 GSK Business Overview
7.10.2 GSK ß-blockers Quarterly Production and Revenue, 2020
7.10.3 GSK ß-blockers Product Introduction
7.10.4 GSK Response to COVID-19 and Related Developments
7.11 Teva Pharmaceutical
7.11.1 Teva Pharmaceutical Business Overview
7.11.2 Teva Pharmaceutical ß-blockers Quarterly Production and Revenue, 2020
7.11.3 Teva Pharmaceutical ß-blockers Product Introduction
7.11.4 Teva Pharmaceutical Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 ß-blockers Supply Chain Analysis
8.1.1 ß-blockers Supply Chain Analysis
8.1.2 Covid-19 Impact on ß-blockers Supply Chain
8.2 Distribution Channels Analysis
8.2.1 ß-blockers Distribution Channels
8.2.2 Covid-19 Impact on ß-blockers Distribution Channels
8.2.3 ß-blockers Distributors
8.3 ß-blockers Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on ß-blockers Assessment
Table 9. COVID-19 Impact: ß-blockers Market Trends
Table 10. COVID-19 Impact Global ß-blockers Market Size
Table 11. Global ß-blockers Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global ß-blockers Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global ß-blockers Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global ß-blockers Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global ß-blockers Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global ß-blockers Market Growth Drivers
Table 17. Global ß-blockers Market Restraints
Table 18. Global ß-blockers Market Opportunities
Table 19. Global ß-blockers Market Challenges
Table 20. Key Manufacturers ß-blockers Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, ß-blockers Market Size, 2019 (K Units) & (US$ Million)
Table 22. ß-blockers Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers ß-blockers Manufacturing Plants
Table 24. Key Manufacturers ß-blockers Market Served
Table 25. Date of Key Manufacturers Enter into ß-blockers Market
Table 26. Key Manufacturers ß-blockers Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global ß-blockers Market Size by Type, 2020, (US$ Million)
Table 29. Global ß-blockers Market Size by Type, 2020 (K Units)
Table 30. Global ß-blockers Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global ß-blockers Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global ß-blockers Market Size by Application, 2020-2021 (K Units)
Table 33. Global ß-blockers Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global ß-blockers Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global ß-blockers Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America ß-blockers Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America ß-blockers Market Size, 2019-2021 (K Units)
Table 38. US ß-blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada ß-blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe ß-blockers Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe ß-blockers Market Size, 2019-2021 (K Units)
Table 43. Germany ß-blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France ß-blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK ß-blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy ß-blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific ß-blockers Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific ß-blockers Market Size, 2019-2021 (K Units)
Table 50. China ß-blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan ß-blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea ß-blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India ß-blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN ß-blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America ß-blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa ß-blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Pfizer Business Overview
Table 58. Pfizer ß-blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Pfizer ß-blockers Product
Table 60. Pfizer Response to COVID-19 and Related Developments
Table 61. Novartis Business Overview
Table 62. Novartis ß-blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Novartis ß-blockers Product
Table 64. Novartis Response to COVID-19 and Related Developments
Table 65. Merck Business Overview
Table 66. Merck ß-blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Merck ß-blockers Product
Table 68. Merck Response to COVID-19 and Related Developments
Table 69. Astra Zeneca Business Overview
Table 70. Astra Zeneca ß-blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Astra Zeneca ß-blockers Product
Table 72. Astra Zeneca Response to COVID-19 and Related Developments
Table 73. Jhonson and Johnson Business Overview
Table 74. Jhonson and Johnson ß-blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Jhonson and Johnson ß-blockers Product
Table 76. Jhonson and Johnson Response to COVID-19 and Related Developments
Table 77. Eli Lilly Business Overview
Table 78. Eli Lilly ß-blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Eli Lilly ß-blockers Product
Table 80. Eli Lilly Response to COVID-19 and Related Developments
Table 81. Sanofi Business Overview
Table 82. Sanofi ß-blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Sanofi ß-blockers Product
Table 84. Sanofi Response to COVID-19 and Related Developments
Table 85. Bristol-Myers Squibb Business Overview
Table 86. Bristol-Myers Squibb ß-blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Bristol-Myers Squibb ß-blockers Product
Table 88. Bristol-Myers Squibb Response to COVID-19 and Related Developments
Table 89. Bayer Business Overview
Table 90. Bayer ß-blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Bayer ß-blockers Product
Table 92. Bayer Response to COVID-19 and Related Developments
Table 93. GSK Business Overview
Table 94. GSK ß-blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. GSK ß-blockers Product
Table 96. GSK Response to COVID-19 and Related Developments
Table 97. Teva Pharmaceutical Business Overview
Table 98. Teva Pharmaceutical ß-blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Teva Pharmaceutical ß-blockers Product
Table 100. Teva Pharmaceutical Response to COVID-19 and Related Developments
Table 101. ß-blockers Distributors List
Table 102. ß-blockers Customers List
Table 103. Covid-19 Impact on ß-blockers Customers
List of FiguresFigure 1. ß-blockers Product Picture
Figure 2. ß-blockers Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global ß-blockers Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global ß-blockers Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global ß-blockers Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global ß-blockers Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global ß-blockers Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global ß-blockers Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific ß-blockers Market Size Market Share, 2019-2021